rs2234677

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000259206.9(IL1RN):​c.-87G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.242 in 837,914 control chromosomes in the GnomAD database, including 27,199 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.21 ( 4092 hom., cov: 32)
Exomes 𝑓: 0.25 ( 23107 hom. )

Consequence

IL1RN
ENST00000259206.9 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.267

Publications

23 publications found
Variant links:
Genes affected
IL1RN (HGNC:6000): (interleukin 1 receptor antagonist) The protein encoded by this gene is a member of the interleukin 1 cytokine family. This protein inhibits the activities of interleukin 1, alpha (IL1A) and interleukin 1, beta (IL1B), and modulates a variety of interleukin 1 related immune and inflammatory responses, particularly in the acute phase of infection and inflammation. This gene and five other closely related cytokine genes form a gene cluster spanning approximately 400 kb on chromosome 2. A polymorphism of this gene is reported to be associated with increased risk of osteoporotic fractures and gastric cancer. Several alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Aug 2020]
IL1RN Gene-Disease associations (from GenCC):
  • sterile multifocal osteomyelitis with periostitis and pustulosis
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 2-113117932-G-A is Benign according to our data. Variant chr2-113117932-G-A is described in ClinVar as Benign. ClinVar VariationId is 330817.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.271 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL1RNXM_011511121.2 linkc.-272-2134G>A intron_variant Intron 3 of 8 XP_011509423.1 P18510-4A0A024R528
IL1RNXM_047444184.1 linkc.-272-2134G>A intron_variant Intron 4 of 9 XP_047300140.1
IL1RNXM_047444185.1 linkc.-273+267G>A intron_variant Intron 4 of 9 XP_047300141.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL1RNENST00000259206.9 linkc.-87G>A 5_prime_UTR_variant Exon 1 of 6 1 ENSP00000259206.5 P18510-3
IL1RNENST00000354115.6 linkc.-87G>A 5_prime_UTR_variant Exon 1 of 5 1 ENSP00000329072.3 P18510-2
IL1RNENST00000361779.7 linkc.-306G>A 5_prime_UTR_variant Exon 1 of 6 1 ENSP00000354816.3 P18510-4

Frequencies

GnomAD3 genomes
AF:
0.209
AC:
31815
AN:
152044
Hom.:
4086
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0582
Gnomad AMI
AF:
0.246
Gnomad AMR
AF:
0.278
Gnomad ASJ
AF:
0.293
Gnomad EAS
AF:
0.0973
Gnomad SAS
AF:
0.284
Gnomad FIN
AF:
0.305
Gnomad MID
AF:
0.215
Gnomad NFE
AF:
0.269
Gnomad OTH
AF:
0.231
GnomAD4 exome
AF:
0.249
AC:
170672
AN:
685750
Hom.:
23107
Cov.:
9
AF XY:
0.250
AC XY:
92648
AN XY:
370026
show subpopulations
African (AFR)
AF:
0.0530
AC:
1000
AN:
18864
American (AMR)
AF:
0.315
AC:
13791
AN:
43728
Ashkenazi Jewish (ASJ)
AF:
0.291
AC:
6197
AN:
21322
East Asian (EAS)
AF:
0.0821
AC:
2984
AN:
36334
South Asian (SAS)
AF:
0.274
AC:
19402
AN:
70790
European-Finnish (FIN)
AF:
0.296
AC:
15655
AN:
52908
Middle Eastern (MID)
AF:
0.214
AC:
710
AN:
3322
European-Non Finnish (NFE)
AF:
0.254
AC:
102401
AN:
403622
Other (OTH)
AF:
0.245
AC:
8532
AN:
34860
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.441
Heterozygous variant carriers
0
6558
13115
19673
26230
32788
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1046
2092
3138
4184
5230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.209
AC:
31830
AN:
152164
Hom.:
4092
Cov.:
32
AF XY:
0.212
AC XY:
15784
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.0580
AC:
2412
AN:
41554
American (AMR)
AF:
0.278
AC:
4252
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.293
AC:
1016
AN:
3470
East Asian (EAS)
AF:
0.0967
AC:
502
AN:
5192
South Asian (SAS)
AF:
0.284
AC:
1367
AN:
4814
European-Finnish (FIN)
AF:
0.305
AC:
3215
AN:
10554
Middle Eastern (MID)
AF:
0.214
AC:
63
AN:
294
European-Non Finnish (NFE)
AF:
0.269
AC:
18287
AN:
67986
Other (OTH)
AF:
0.233
AC:
492
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1200
2400
3600
4800
6000
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
350
700
1050
1400
1750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.247
Hom.:
4681
Bravo
AF:
0.199

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
May 12, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 45% of patients studied by a panel of primary immunodeficiencies. Number of patients: 43. Only high quality variants are reported. -

Sterile multifocal osteomyelitis with periostitis and pustulosis Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
4.9
DANN
Benign
0.69
PhyloP100
-0.27
PromoterAI
0.019
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2234677; hg19: chr2-113875509; COSMIC: COSV52079920; COSMIC: COSV52079920; API